Dynasil's RMD Subsidiary Supplying Thermo Fisher Scientific with CLYC for New RadEye SPRD-GN Detector

WATERTOWN, Mass., Nov. 2, 2016 /PRNewswire/ -- Dynasil Corporation of America (NASDAQ: DYSL) today announced that its subsidiary, RMD Inc., will be supplying Thermo Fisher Scientific with packaged solid state detectors based on RMD's Cs₂LiYCl₆:Ce (CLYC) scintillation crystals for use in Thermo's new RadEye SPRD-GN spectroscopic personal radiation detectors.

Security professionals seeking reliable radiation detection and identification for remote locations can now use Thermo Scientific's pocket-size search-and-find detector that is designed for high-sensitivity and accuracy.  Utilizing CLYC, the new detector provides both gamma and neutron detection, enabling first responders to quickly locate and identify a wide range of radioactive materials with a single device.

CLYC can distinguish gamma-ray and neutron radiation using pulse height discrimination (PHD) as well as more powerful pulse shape discrimination (PSD) and the RadEye SPRD-GN utilizes these powerful capabilities of CLYC.  CLYC is also capable of high resolution gamma ray spectroscopy.  This feature enables the RadEye SPRD-GN to provide accurate identification of the detected radiation.

"RMD's world-class research and manufacturing in nuclear detection continues to be on the cutting edge of new technologies," said Kanai Shah, Ph. D., President of Dynasil's RMD subsidiary.  "For the past several years, RMD has collaborated with our OEM partner Thermo Fisher Scientific on the development of this RadEye SPRD product, a state of the art instrument for radiation detection.  CLYC is an example of our research transitioning into products that make a real world difference in protecting the United States from illicit nuclear materials." 

About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management. These forward-looking statements may be identified by the use of words such as "may," "could," "expect," "estimate," "anticipate," "continue" or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to develop and commercialize our products, including our dual mode detectors and the development of new technologies including at Dynasil Biomedical, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management personnel, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company's Annual Report on Form 10-Kand from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Patty Kehe
Dynasil Corporation of America
Phone: 617.668.6855
Email: [email protected]

SOURCE Dynasil Corporation of America

Related Links

http://www.dynasil.com